My main concern is the possible disruption of the Ibrutinib supply. Any information?
Here is the answer from Tom Henry, our expert pharmacist:
I checked the FDA drug shortage website and at present, ibrutinib is not in shortage situation. This of course can change rapidly. Ibrutinib is made in Guangzhu Nansha, China so there is at a minimum some risk of disruption in shipments. On a positive note, the city of Nansha is a port city near Hong Kong so internal transportation within China is less of fa actor as it might be if the plant was further inland.
In the meantime, you can take personal action to try to increase your drug on hand. Insurance companies will pay for your prescription when your stock has reached the 75% point so a 30 day prescription can be filled every 25 days and a 3 month prescription every 75 days so it is possible to get a little ahead.
We will keep our followers alert if we learn of any disruption of supplies.
Remember that we cannot give medical advice and any suggestions should be reviewed with your treating doctors.